EMA Warns of Dangerous Fake Weight Loss Drugs Flooding the Market
The European Medicines Agency (EMA) has issued a serious warning about a sharp rise in illegal weight loss drugs being […]
The European Medicines Agency (EMA) has issued a serious warning about a sharp rise in illegal weight loss drugs being […]
A recent government notice confirmed the dates for an important meeting where experts will discuss and possibly vote on recommendations
Teva Pharmaceuticals has received US approval for its generic version of liraglutide, a drug used to help with weight loss.
Here’s a quick rundown of recent news from major pharmaceutical companies that you might have missed. Amylyx Pharmaceuticals announced that
Starting in January 2026, the NHS in England will provide the chickenpox vaccine to children as part of their routine
A major study by Eli Lilly has found that patients with early-stage breast cancer who took Verzenio along with standard
Novo Nordisk, the company behind popular weight loss and diabetes drugs Ozempic and Wegovy, is teaming up with Replicate Bioscience
Stay informed about the latest in drug development with BioPharma Dive’s free newsletter, delivered straight to your inbox. In the
The obesity drug market is currently dominated by two major players: Eli Lilly and Novo Nordisk. Both companies are working
A report from the Make America Healthy Again (MAHA) Commission was delayed earlier this month, but leaked documents reveal plans